KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) EBT Margin (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed EBT Margin for 11 consecutive years, with 8121.25% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 812506.0% to 8121.25% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.45% through Dec 2025, up 1307.0% year-over-year, with the annual reading at 2.56% for FY2025, 1395.0% up from the prior year.
  • EBT Margin hit 8121.25% in Q4 2025 for Fulgent Genetics, up from 8.93% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 8121.25% in Q4 2025 to a low of 205.94% in Q4 2023.
  • Historically, EBT Margin has averaged 426.12% across 5 years, with a median of 3.81% in 2024.
  • Biggest five-year swings in EBT Margin: plummeted -9488bps in 2023 and later surged 812506bps in 2025.
  • Year by year, EBT Margin stood at 59.93% in 2021, then tumbled by -97bps to 1.66% in 2022, then tumbled by -12484bps to 205.94% in 2023, then surged by 98bps to 3.81% in 2024, then surged by 213385bps to 8121.25% in 2025.
  • Business Quant data shows EBT Margin for FLGT at 8121.25% in Q4 2025, 8.93% in Q3 2025, and 26.31% in Q2 2025.